Skip to main content

HSV Infection clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • A Study of a Potential New Treatment of HSV Infection (Herpes Simplex Virus)

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 16 years and up

    Randomized, open-label, multi-center, comparative trial to assess the efficacy and safety in immunocompromised subjects with acyclovir resistant or acyclovir susceptible mucocutaneous HSV infection, treated with pritelivir 100 mg once daily (following a loading dose of 400 mg as first dose to rapidly reach steady-state plasma concentration) or foscarnet 40 mg/kg every 8 hours or 60 mg/kg every 12 hours.

    at UC Davis

Last updated: